13Jul
Experts Challenge FDA Over Approval for New Dose of Alzheimer’s Drug
By
Approval for a new dose of a best-selling Alzheimer’s drug “breached the FDA’s own regulatory standard” and has led to “incomplete and distorted messages” about the drug, warn experts on bmj.com today.
Experts Challenge FDA Over Approval for New Dose of Alzheimer’s Drug
Tags: Alzheimer's drug, FDA
